Diethylamino-curcumin mimic with trizolyl benzene enhances TRAIL-mediated cell death on human glioblastoma cells

ConclusionThese results demonstrated that YM-4 can be an anticancer candidate that can be effective on human glioblastoma cells in combination with TRAIL.

Source: Molecular and Cellular Toxicology - March 24, 2018 Category: Cytology Source Type: research